These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6557688)

  • 21. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
    Rosing J; Tans G; Griffin JH
    Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An automated chromogenic peptide substrate assay for coagulation factor XII.
    Jones DW; Gallimore MJ; Winter M
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):183-7. PubMed ID: 9622217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanized assay of plasma prekallikrein by activation with Pseudomonas aeruginosa elastase and amidolysis of chromogenic substrate.
    Shibuya Y; Yamamoto T; Tanaka H; Semba U; Kambara T; Okabe H
    Clin Chim Acta; 1991 Aug; 200(2-3):119-27. PubMed ID: 1777962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays.
    Saito H
    Adv Exp Med Biol; 1979; 120A():165-72. PubMed ID: 573961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].
    Baskova IP; Paskhina TS; Poliantseva LR; Iakubovskaia RI; Tiero A
    Vopr Med Khim; 1983; 29(5):96-9. PubMed ID: 6557709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on plasma prekallikrein assay method with chromogenic substrates (S-2302)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1983 Feb; 31(2):219-22. PubMed ID: 6190027
    [No Abstract]   [Full Text] [Related]  

  • 34. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation.
    Pixley RA; Stumpo LG; Birkmeyer K; Silver L; Colman RW
    J Biol Chem; 1987 Jul; 262(21):10140-5. PubMed ID: 2440859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factor XII (HAGEMAN FACTOR)].
    Kase F; Klír P; Pospísil J; Poucková P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C; Stürzebecher J; Markwardt F
    Thromb Res; 1982 Mar; 25(6):501-5. PubMed ID: 6921902
    [No Abstract]   [Full Text] [Related]  

  • 39. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The function of the heavy and light chain of human plasma kallikrein in the activation of factor XII.
    Rosing J; Tans G; Griffin JH
    Adv Exp Med Biol; 1986; 198 Pt B():27-34. PubMed ID: 3492870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.